178 related articles for article (PubMed ID: 7751034)
1. Reduced lysis by CD8+ cytotoxic T cells in mixed lymphocyte reactions induced via CD4+ T cells exposed to chemically modified antigen presenting cells.
Corlett L; Davies DH
Immunology; 1995 Mar; 84(3):488-94. PubMed ID: 7751034
[TBL] [Abstract][Full Text] [Related]
2. Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6.
Renauld JC; Vink A; Van Snick J
J Immunol; 1989 Sep; 143(6):1894-8. PubMed ID: 2528583
[TBL] [Abstract][Full Text] [Related]
3. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
[TBL] [Abstract][Full Text] [Related]
4. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
5. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
Liu QS; Zhang RH; Chu YW; Xiong SD
Sheng Li Xue Bao; 2003 Dec; 55(6):633-40. PubMed ID: 14695478
[TBL] [Abstract][Full Text] [Related]
6. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
7. Antigen-independent activation of memory cytotoxic T cells by interleukin 2.
Lefrancois L; Klein JR; Paetkau V; Bevan MJ
J Immunol; 1984 Apr; 132(4):1845-50. PubMed ID: 6230394
[TBL] [Abstract][Full Text] [Related]
8. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
9. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
[TBL] [Abstract][Full Text] [Related]
10. Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells.
Okumura C; Suto R; Furukawa K; Ahmed SS; Furukawa K; Nakayama E; Fujii T; Shiku H
J Immunol; 1995 Feb; 154(3):1114-23. PubMed ID: 7822788
[TBL] [Abstract][Full Text] [Related]
11. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
12. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
13. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
14. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytolytic T cell responses by heparan sulfate.
Wrenshall LE; Carlson A; Cerra FB; Platt JL
Transplantation; 1994 Apr; 57(7):1087-94. PubMed ID: 8165708
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
Yang AS; Lattime EC
Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
[TBL] [Abstract][Full Text] [Related]
17. Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.
Wada H; Ono T; Uenaka A; Monden M; Nakayama E
Immunology; 1995 Apr; 84(4):633-7. PubMed ID: 7790038
[TBL] [Abstract][Full Text] [Related]
18. The human antimurine xenogeneic cytotoxic response. I. Dependence on responder antigen-presenting cells.
Lucas PJ; Shearer GM; Neudorf S; Gress RE
J Immunol; 1990 Jun; 144(12):4548-54. PubMed ID: 1972159
[TBL] [Abstract][Full Text] [Related]
19. Lead enhances CD4+ T cell proliferation indirectly by targeting antigen presenting cells and modulating antigen-specific interactions.
Farrer DG; Hueber SM; McCabe MJ
Toxicol Appl Pharmacol; 2005 Sep; 207(2):125-37. PubMed ID: 15885731
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
